This week’s Conference on Retroviruses and Opportunistic Infections (CROI 2024) heard the latest data from research involving giving people a cocktail of three broadly neutralising antibodies (bnAbs), which aidsmap last reported on two years ago.
In the latest study, Dr Boris Juelg and colleagues from the Ragon Institute in Massachusetts worked with 12 people with HIV, who stopped their antiretrovirals (ARVs) and instead received the triple bnAb combination. Of these, four and possibly five people (one was lost to follow-up) maintained undetectable viral loads off any HIV therapy to the end of the study period, more than six months after their last bnAb injection. Another five study participants did experience viral rebound, but not till 4 to 6 months after their last bnAb injection. Only two people had early viral failure.
Read the full story at Aidsmap.
Source : Aidsmap
Related HIV and Co-Infections News
-
Queen Mary University of London: Scientists discover how HIV hijacks a cellular ‘gateway’ to infect resting immune cells
-
Science: A novel gene-therapy approach to ‘functionally cure’ HIV succeeds in some monkeys
-
TheBody: RIP Loreen Willenberg, who gave her HIV-proof body to science and her heart to the community
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.